Top Healthcare companies in United States by Net Income Margin

This ranking features the top 470 Healthcare companies in United States ranked by Net Income Margin, averaging a Net Income Margin of -7,491.27%, for February 04, 2025.

United States

Healthcare

#	Name	Net Income Margin	Reported Date	Stock Price	Change	Country
1	Inhibrx Biosciences, Inc. 1 INBX	94,684.72%	Sept. 30, 2024	USD 12.72	-6.33%	United States
2	Agios Pharmaceuticals, Inc. 2 AGIO	2,051.38%	Sept. 30, 2024	USD 33.62	-2.24%	United States
3	Edwards Lifesciences Corporation 3 EW	70.82%	Sept. 30, 2024	USD 71.38	-1.48%	United States
4	Protagonist Therapeutics, Inc. 4 PTGX	52.76%	Sept. 30, 2024	USD 37.20	-1.59%	United States
5	SIGA Technologies, Inc. 5 SIGA	49.33%	Sept. 30, 2024	USD 5.78	-3.34%	United States
6	Royalty Pharma plc 6 RPRX	48.20%	Dec. 31, 2023	USD 31.33	-0.79%	United States
7	Halozyme Therapeutics, Inc. 7 HALO	41.43%	Sept. 30, 2024	USD 56.28	-0.64%	United States
8	United Therapeutics Corporation 8 UTHR	40.31%	Sept. 30, 2024	USD 354.58	0.97%	United States
9	Utah Medical Products, Inc. 9 UTMD	34.62%	Sept. 30, 2024	USD 59.92	-2.14%	United States
10	Doximity, Inc. 10 DOCS	33.69%	Sept. 30, 2024	USD 59.10	NA	United States
11	Regeneron Pharmaceuticals, Inc. 11 REGN	33.61%	Sept. 30, 2024	USD 666.85	-0.91%	United States
12	Catalyst Pharmaceuticals, Inc. 12 CPRX	31.01%	Sept. 30, 2024	USD 22.62	0.27%	United States
13	Lantheus Holdings, Inc. 13 LNTH	28.57%	Sept. 30, 2024	USD 89.54	-3.21%	United States
14	Intuitive Surgical, Inc. 14 ISRG	28.51%	Sept. 30, 2024	USD 578.55	1.17%	United States
15	MiMedx Group, Inc. 15 MDXG	28.49%	Sept. 30, 2024	USD 8.54	-1.84%	United States
16	Semler Scientific, Inc. 16 SMLR	27.00%	Sept. 30, 2024	USD 50.46	-2.89%	United States
17	IRadimed Corporation 17 IRMD	26.12%	Sept. 30, 2024	USD 59.35	0.24%	United States
18	Entrada Therapeutics, Inc. 18 TRDA	25.53%	Sept. 30, 2024	USD 13.33	-0.82%	United States
19	ResMed Inc. 19 RMD	25.35%	Dec. 31, 2024	USD 240.55	1.85%	United States
20	Insulet Corporation 20 PODD	23.22%	Sept. 30, 2024	USD 278.90	0.19%	United States
21	Corcept Therapeutics Incorporated 21 CORT	22.48%	Sept. 30, 2024	USD 66.55	-0.55%	United States
22	Exelixis, Inc. 22 EXEL	22.43%	Sept. 27, 2024	USD 32.88	-0.81%	United States
23	Roper Technologies, Inc. 23 ROP	22.01%	Dec. 31, 2024	USD 577.04	0.24%	United States
24	Amphastar Pharmaceuticals, Inc. 24 AMPH	21.87%	Sept. 30, 2024	USD 33.39	-4.24%	United States
25	Krystal Biotech, Inc. 25 KRYS	21.68%	Sept. 30, 2024	USD 159.03	-0.44%	United States
26	Waters Corporation 26 WAT	21.43%	Sept. 28, 2024	USD 411.19	-1.03%	United States
27	Eli Lilly and Company 27 LLY	20.48%	Sept. 30, 2024	USD 810.43	-0.08%	United States
28	Organon & Co. 28 OGN	20.30%	Sept. 30, 2024	USD 14.91	-4.18%	United States
29	Agilent Technologies, Inc. 29 A	19.80%	Oct. 31, 2024	USD 148.63	-1.91%	United States
30	Hologic, Inc. 30 HOLX	19.59%	Sept. 28, 2024	USD 71.72	-0.58%	United States
31	LeMaitre Vascular, Inc. 31 LMAT	19.40%	Sept. 30, 2024	USD 95.43	-1.55%	United States
32	Merck & Co., Inc. 32 MRK	19.22%	Sept. 30, 2024	USD 99.79	0.98%	United States
33	National Research Corporation 33 NRC	18.79%	Sept. 30, 2024	USD 16.36	-1.86%	United States
34	Harmony Biosciences Holdings, Inc. 34 HRMY	17.98%	Sept. 30, 2024	USD 38.70	-0.18%	United States
35	ADMA Biologics, Inc. 35 ADMA	17.80%	Sept. 30, 2024	USD 16.47	1.98%	United States
36	Innoviva, Inc. 36 INVA	17.79%	Sept. 30, 2024	USD 18.41	-1.23%	United States
37	Medpace Holdings, Inc. 37 MEDP	17.65%	Sept. 30, 2024	USD 343.38	-1.65%	United States
38	West Pharmaceutical Services, Inc. 38 WST	17.37%	Sept. 30, 2024	USD 337.03	-1.32%	United States
39	DexCom, Inc. 39 DXCM	17.22%	Sept. 30, 2024	USD 87.05	0.25%	United States
40	Neurocrine Biosciences, Inc. 40 NBIX	17.21%	Sept. 30, 2024	USD 150.10	-1.13%	United States
41	Biogen Inc. 41 BIIB	17.17%	Sept. 30, 2024	USD 142.34	-1.10%	United States
42	Johnson & Johnson 42 JNJ	16.74%	Sept. 29, 2024	USD 151.87	-0.18%	United States
43	Danaher Corporation 43 DHR	16.33%	Dec. 31, 2024	USD 214.26	-3.81%	United States
44	Fortive Corporation 44 FTV	16.00%	Sept. 27, 2024	USD 80.24	-1.34%	United States
45	Voyager Therapeutics, Inc. 45 VYGR	15.80%	Sept. 30, 2024	USD 5.33	-2.20%	United States
46	American Shared Hospital Services 46 AMS	15.74%	Sept. 30, 2024	USD 3.15	2.27%	United States
47	Tenet Healthcare Corporation 47 THC	14.91%	Sept. 30, 2024	USD 144.64	2.66%	United States
48	Collegium Pharmaceutical, Inc. 48 COLL	14.78%	Sept. 30, 2024	USD 31.20	-2.86%	United States
49	Thermo Fisher Scientific Inc. 49 TMO	14.78%	Dec. 31, 2024	USD 593.75	-0.67%	United States
50	Zimmer Biomet Holdings, Inc. 50 ZBH	14.27%	Sept. 30, 2024	USD 108.16	-1.21%	United States

1 2 3 4 … 10

Frequently Asked Questions

Which Healthcare company in United States has the highest Net Income Margin ?

The Healthcare company in United States with the highest Net Income Margin is Inhibrx Biosciences, Inc. (NasdaqGS: INBX) at 94,684.72%.
Which Healthcare company in United States has the lowest Net Income Margin ?

The Healthcare company in United States with the lowest Net Income Margin is Inhibikase Therapeutics, Inc. (NasdaqCM: IKT) at -1,956,524,900.00%.

What are the top 10 Healthcare companies in United States by Net Income Margin ?

The top 10 Healthcare companies in United States by Net Income Margin are Inhibrx Biosciences, Inc., Agios Pharmaceuticals, Inc., Edwards Lifesciences Corporation, Protagonist Therapeutics, Inc., SIGA Technologies, Inc., Royalty Pharma plc, Halozyme Therapeutics, Inc., United Therapeutics Corporation, Utah Medical Products, Inc. and Doximity, Inc..
What are the bottom 10 Healthcare companies in United States by Net Income Margin ?

The bottom 10 Healthcare companies in United States by Net Income Margin are Inhibikase Therapeutics, Inc., Immix Biopharma, Inc., Bullfrog AI Holdings, Inc. Common Stock, Benitec Biopharma Inc., Altimmune, Inc., Greenwich LifeSciences, Inc., Allogene Therapeutics, Inc., Acelyrin, Inc., 89bio, Inc. and INmune Bio, Inc..

Frequently Asked Questions

Don’t Miss A Beat